Alan Robin

This user account status is Approved
Robin
Alan
United States

He developed apraclonidine for glaucoma and was the first to perform and publish on Nd:Yag laser iridotomy; Performed the first modern prevalence study of eye diseases in India; Has published seminal articles on the use of lasers, drugs, and surgery for glaucoma

medication development
lasers
surgery
pseudoexfoliation


Sessions


Thursday 3.45 pm-4.45 pmRoom 218

When the going gets tough: Making it easier for your patient

Chair(s): Alan Robin (United States); Ivan Goldberg (Australia);

  • 3.45-3.55
    Maximizing adherence to minimize disease
    Michael Boland (United States)
  • 3.55-4.05
    Apps & aids to assist the patient with severe glaucoma
    Mona Kaleem (United States)
  • 4.05-4.15
    Optimizing the ocular surface for comfort and vision
    Jod Mehta (Singapore)
  • 4.15-4.25
    Maximizing functionality and Minimizing disability in the advanced glaucoma patient
  • 4.25-4.35
    Living with glaucoma: the patient's perspective
  • 4.35-4.45
    What do patient's want from glaucoma surgery?
    Amanda Bicket (United States)

Thursday 5.00 pm-6.00 pmRoom 219

Analyzing the evidence

Chair(s): Jeffrey Liebmann (United States); Ravi Thomas (Australia);

Friday 3.45 pm-4.45 pmRoom 218

Convince your government and payors that what you do is useful & cost-effective

Chair(s): Jennifer Burr (United Kingdom); Anja Tuulonen (Finland);

Contact

Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

MCI Amsterdam
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands
www.mci-group.com
wgc@mci-group.com